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e-mail address: kaustubh.m@hotmail.com (K. Mulay).Kaustubh Mulay, DNB a,b,⇑; Santosh G. Honavar, MS, FACS c,dAbstractMucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexae is rare. A 39-year-old woman presenting with
proptosis was diagnosed to have non-Hodgkin’s lymphoma with intermediate-sized cells and lymphoepithelial lesion. Unlike most
MALT lymphomas, this lymphoma was found to be CD5-positive. Small lymphocytic lymphoma/chronic lymphocytic leukemia and
lymphoplasmacytic lymphoma are two other entities that are CD5-positive and have a morphological pattern similar to MALT
lymphoma. The case report and approach to the diagnosis is discussed.
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Mucosa-associated lymphoid tissue (MALT) – type mar-
ginal zone lymphoma (MZL) involves organs that normally
lack lymphoid tissue. No specific immunohistochemical mar-
ker exists for MALT lymphomas. Usually known to be CD5-
negative, they might rarely exhibit CD5-immunoreactivity.1,2
We report on a 39-year-old woman with a CD5-positive
MALT lymphoma of the lacrimal gland.Case report
A 39-year-old woman presented with symptoms of swell-
ing in the left eye and diplopia for 2 months (Fig. 1a). She
was unaware of any systemic illness. On examination, she
had 8-mm abaxial proptosis with 4 mm hypoglobus
(Fig. 1b) and restriction of ocular movements in abductionand elevation. A firm mass was palpable in the superotempo-
ral orbit in the region of the lacrimal gland. There were no
signs of local inflammation. Schermer 1 values were 35 mm
in 5 min in the right eye and 21 mm in the left eye. Rest of
the ocular examination was unremarkable. Computed
tomography showed an isodense diffuse mass involving the
left lacrimal gland, extending laterally to involve the lateral
rectus muscle with (Fig. 1c). Clinical diagnosis of lymphopro-
liferative lesion or nonspecific orbital inflammation was
considered and a transperiosteal incisional biopsy was per-
formed by a sub-brow anterior orbitotomy approach.
Microscopic examination showed a dense, neoplastic
lymphoid infiltrate involving the lacrimal gland with splaying
and partial destruction of the entrapped lacrimal gland
tissue. Lymphoepithelial lesions with infiltration of acini by
neoplastic cells were seen. The neoplastic lymphoid cells
were intermediate-sized with scant cytoplasm and an
irregular nucleus. Some cells had a plasmacytoid appearance.e:
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Figure 1. (a and b) Abaxial proptosis and hypoglobus of left eye. (c) CT scan showing a homogenous mass in the left orbit in the region of lacrimal gland
with extension to involve the lateral rectus.
MALT-lymphoma lacrimal gland 339Conspicuous nucleoli were seen in some cells (Fig. 2). The
tumor cells expressed immunoreactivity for CD20, CD5 and
Bcl-2 (Fig. 3) but were negative for CD10, CD23, CD30,
TdT, Cyclin D1, Bcl-6 and CD3. A monotypical IgM expres-
sion was seen. Ki-67 labeling index was moderate up to a
maximum of 15%. CD3-positive, reactive T-cells were seen
in the background. Bone marrow and peripheral blood exam-
ination were normal. Systemic examination was normal. A
diagnosis of CD5-positive MALT lymphoma was made. The
patient was treated with 4000 cGy fractionated external
beam radiotherapy to the left orbit. She is alive and well with
complete regression at 5 months follow-up.
Discussion
Lymphomas involving the orbit and ocular adnexae are
rare. MALT lymphoma appears to be the most frequent ocu-
lar adnexal lymphoma. MZLs are a group of indolent B-cell
non-Hodgkin’s lymphomas that arise from the marginal zoneFigure 2. (a) Diffuse lymphoid tumor infiltrating and destroying the lacrimal
centers (H and E 40). (c) Infiltration of lacrimal acini with neoplastic lymphoid
sized, centrocyte-like neoplastic lymphoid cells (H and E 400).of lymphoid tissues. The World Health Organization (WHO)
classifies them into 3 distinct types: splenic MZL, nodal
MZL, and MALT lymphoma (or extranodal MZL). MALT lym-
phoma differs from its splenic and nodal counterparts as it
arises in organs that normally lack lymphoid tissue (like stom-
ach, lung, and salivary and lachrymal glands) but have accu-
mulated B-cells in response to either chronic infections or
autoimmune processes. Initially described to involve the
stomach, MALT lymphoma has now been described to occur
in the salivary gland, thyroid, intestine, lacrimal gland, con-
junctiva and skin. MALT lymphomas are preceded by chronic
antigenic stimulation and involve deregulation of the nuclear
factor jB (NF-jB) pathway. Chlamydia psittaci is supposedly
an important etiologic agent in the histogenesis of orbital
MALT lymphoma.3 MALT lymphomas are characterized by
infiltration of neoplastic lymphoid cell between pre-existing
follicles. The morphology of these neoplastic cells may vary
within the same tumor. The tumor cells are of intermediate
size with a scant cytoplasm and an irregular nucleusgland (H and E 20). (b) Lymphoid follicles with pale staining germinal
cells forming lymphoepithelial lesions (H and E 400). (d) Intermediate-
Figure 3. (a) Immunoreactivity of tumor cells for CD20 (400). (b) Cytoplasmic immunoreactivity of tumor cells for Bcl-2 (400). (c) Immunoreactivity for
Ki-67 (400) and (d) Immunoreactivity of tumor cells for CD5 (400).
340 K. Mulay, S.G. Honavarresembling centrocytes of the follicular center. Plasma cell
differentiation is seen and may sometimes be prominent.
The bona fide epithelial and mucosal injury, typified by the
so-called ‘‘lymphoepithelial lesion’’, characterized by cluster-
ing of neoplastic cells infiltrating and destroying the glandu-
lar epithelium, helps diagnose MALT-lymphomas.4 There is
no specific marker for MALT-lymphoma. Immunohistochemi-
cally, the neoplastic MALT lymphoma cells co-express CD20
and surface light-chain restriction but are negative for CD10
and CD5. Rarely, CD5 immunoreactivity has been described
in MALT lymphomas.1,2 The role of CD5 expression in the
prognosis of MALT-lymphomas is controversial.5 Its aberrant
expression was thought to be related to an aggressive
behavior. However, reports of indolent CD5-positive MALT
lymphomas exist in literature.2 Lymphoblastic lymphoma
(LPL) and small cell lymphoma/chronic lymphocytic leukemia
(SLL/CLL) are other CD5-positive, B-cell lymphoproliferative
disorders that share morphology similar to MALT lympho-
mas. Absence of immunoexpression for CD23, as seen in
our case, would rule out a SLL which is almost invariably
CD23-positive. LPL may have a CD23-negative immunophe-
notype similar to MALT lymphoma. A thorough systemic
examination would help in this case. LPL and SLL/CLL are sys-
temic diseases while MALT lymphoma is localized to extran-
odal regions.
MALT lymphoma is a B-cell lymphoproliferative disease
that is usually CD5-negative but may rarely express aCD5-immunoreactivity. It being a localized disease of extran-
odal sites, rarely shows systemic involvement, and can be
treated with local excision or external beam radiotherapy.
Hence, its distinction from other CD5-positive lymphomas
with a similar morphology becomes important.
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